PriceVH. Double blind, placebo controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol1987; 16:730–736.
5.
PriceVH. Topical minoxidil 3% in extensive alopecia areata including long term efficacy. J Am Acad Dermatol1987; 16:737–744.
6.
Fiedler-WeissV. Alopecia areata: Current therapy. J Invest Dermatol1991; 96:69S–70S.
7.
Fiedler-WeissVBuysC. Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol1986; 122:180–182.
8.
ShapiroJ. Topical Immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin1993; 11:611–617.
9.
ShapiroJTanJHoV. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenoneand 5% minoxidil: A clinical and immunopathologic evaluation. J Am Acad Dermatol1993; 29:729–735.
10.
Van der SteenHappleR. Dyschromia in confetti as a side effect of topical immunotherapy with topical diphenylcyclopropenone. Arch Dermatol1992; 128:518–520.
11.
TaylorCHawkJ. PUVA treatment for alopecia areata, partialis totalis and universalis: Audit of 10 years experience at St. Johns Institute. Br J Dermatol1995; 133:914–918.
12.
ShapiroJLuiHTronV. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: A clinical and immunopathologic evaluation. J Am Acad Dermatol1997; 36:114–117.
13.
MacDonald-HullSPepallLCunliffeW. Alopecia areata in children: Response to treatment with diphencyprone. Br J Dermatol1991; 125:164–168.
14.
TostiAGuidettiMBardazziF. Long term results of topical immunotherapy in children with alopecia totalis or universalis. J Am Acad Dermatol1996; 35:199–201.